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Background: Cigarette smoke yields of tar and nicotine ob-
tained under the Federal Trade Commission (FTC)-specified
machine-smoking protocol (35-mL puff volume drawn for 2
seconds once per minute) may not accurately reflect the de-
livery of toxins and carcinogens to the smoker. We con-
ducted this study to obtain more realistic estimates of expo-
sure to components of cigarette smoke that affect lung
cancer risk. Methods:We used a pressure transducer system
to evaluate puffing characteristics for 133 smokers of ciga-
rettes rated by the FTC at 1.2 mg of nicotine or less (56
smokers of low-yield cigarettes [<0.8 mg of nicotine per
cigarette] and 77 smokers of medium-yield cigarettes [0.9–
1.2 mg of nicotine per cigarette]). We programmed measure-
ments from a randomly chosen subset of 72 of these smokers
into a piston-type machine to generate smoke from each
smoker’s usual brand of cigarettes for assays of nicotine,
carbon monoxide, tar, and the lung cancer-causing agents
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and ben-
zo[a]pyrene. The FTC protocol was also used to assess levels
of targeted components in the 11 brands most frequently
smoked by study subjects.Results:Compared with the FTC
protocol values, smokers of low- and medium-yield brands
took in statistically significantly larger puffs (48.6 and 44.1
mL, respectively) at statistically significantly shorter inter-
vals (21.3 and 18.5 seconds, respectively), and they drew
larger total smoke volumes than specified in the FTC pa-
rameters. They received, respectively, 2.5 and 2.2 times more
nicotine and 2.6 and 1.9 times more tar than FTC-derived
amounts, as well as about twofold higher levels of benzo[a]-
pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-buta-
none. Smokers of medium-yield cigarettes compared with
smokers of low-yield cigarettes received higher doses of all
components.Conclusions:The FTC protocol underestimates
nicotine and carcinogen doses to smokers and overestimates
the proportional benefit of low-yield cigarettes. Thus, FTC-
based nicotine medication doses prescribed/recommended
for smoking cessation may need to be reassessed. [J Natl
Cancer Inst 2000;92:106–11]
In the United States, the incidence of lung cancer among men
and women rose substantially after World War II. Incidence
among men started to decline in the mid-1980s; however, inci-
dence among women has only recently decelerated but not de-
clined (1). Lung cancer has been the leading cause of cancer
deaths among U.S. men since 1960 and among U.S. women
since 1987. An estimated 90.3% of lung cancer deaths in men
and 78.5% of lung cancer deaths in women are attributable to
cigarette smoking. The earliest large-scale epidemiologic studies
on cigarette smoking and lung cancer(2–4) demonstrated a
dose–response relationship between the number of cigarettes
smoked and the risk of lung cancer. This observation was
strongly supported by associations between the amount of “tar”
applied to mouse epidermis and the incidence and multiplicity
of skin tumors(5,6). Since then, numerous carcinogens have
been identified in the tar of mainstream tobacco smoke. (Main-
stream smoke is the smoke that is released at the mouth end
of the cigarette during puffing, as distinguished from sidestream
smoke, which is released from the burning cone between puffs.)
Among these carcinogens, some polycyclic aromatic hydrocar-
bons, such as benzo[a]pyrene (BaP), and some tobacco-specific
N-nitrosamines, such as 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK), are considered to be major lung carcino-
gens(7).
During the past four decades, the sales-weighted average tar
and nicotine smoke yields decreased by more than 60%, from 38
and 2.7 mg per cigarette in 1954 to 13 and 0.9 mg in 1993,
respectively(7–10).It was, therefore, reasonable to expect that
reduction in smokers’ intake of tar would eventually lead to
reduction in lung cancer risk. However, smokers of contempo-
rary cigarettes have not experienced a proportionate reduction in
lung cancer risk. In a case–control study(11,12),we found no
difference in risk of adenocarcinoma of the lung between life-
time smokers of filter cigarettes and lifetime smokers of nonfil-
ter cigarettes. Comparison of data from two American Cancer
Society cohort studies(13) showed that the death rate from lung
cancer in smokers evaluated from 1982 through 1989 was twice
that in smokers evaluated from 1960 through 1966.
Large reductions in lung cancer incidence have not been ob-
served after the introduction of low-yield cigarettes. A possible
explanation is that smokers responded to the low-yield cigarettes
by changing their smoking behavior so that they obtained the
desired level of nicotine, whose concentration in mainstream
smoke is highly correlated with that of tar. Cigarette smokers
draw puffs with an intensity that apparently seeks to satisfy a
conditioned need for nicotine, the major pharmacoactive agent
in tobacco and tobacco smoke that induces tobacco dependence
(14). It has been reported that consumers of contemporary low-
and medium-yield cigarettes (rated by the Federal Trade Com-
mission [FTC], Washington, DC, at 1.2 mg or less of nicotine
per cigarette) inhale smoke more intensely and/or deeply than
smokers of cigarettes with higher nicotine emission(15–20).
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The effect of these behavioral adaptations on lung cancer risk
is not readily evaluated because of the difficulty in measuring
the doses of the carcinogens and co-carcinogens in cigarette
smoke actually inhaled by the smoker and because of the ne-
cessity of relating those doses to metabolic biomarkers of car-
cinogen uptake. Few such dose measurements have been re-
ported. The amount of tar and nicotine in cigarette smoke is
commonly reported on the basis of standardized laboratory pro-
cedures that conform to the FTC machine-smoking protocol.
This protocol specifies that each cigarette be machine smoked to
a standard butt length by use of a 35-mL puff volume drawn over
2 seconds at a rate of one puff per minute(21,22).This smoking
pattern may have approximated the habits of consumers who
smoked nonfilter, nicotine-rich (>2 mg) cigarettes in the 1930s
when machine-smoking methods were first standardized(23–
25). However, studies in our own(26–29)and in other(29,30)
laboratories have shown that, on average, smokers of contem-
porary cigarettes with an average yield of 0.9 mg of nicotine per
cigarette (from the FTC method) are more likely to draw 50-mL
puffs at the rate of two to three puffs per minute. The total
volume of smoke thus generated and, consequently, the body
burden of smoke toxins and carcinogens may differ substantially
from the amounts produced under the FTC protocol.
This study was undertaken to determine how the dose deliv-
ered to the smoker relates to the nominal FTC yield and whether
this delivered dose differs meaningfully between smokers of
low- and medium-yield cigarettes. These low- and medium-yield
cigarettes now account for more than 80% of all brands con-
sumed in the United States. Our secondary goal was to assess
whether intake of BaP and NNK differed between smokers of
low-yield and medium-yield cigarettes. These data should help
in the evaluation of proposed revisions to the existing FTC pro-
tocol for generating tar, nicotine, and carbon monoxide yields in
cigarette smoke(31).
METHODS
Study Population and Procedures
One hundred thirty-three current smokers, between 18 and 59 years of age,
were recruited in Westchester County, NY, through advertisements in local
newspapers. Eligibility was determined in a brief telephone interview. Subjects
had to have smoked only cigarettes with FTC-rated nicotine yields of less than
1.2 mg for at least 3 years and to have smoked their current brand for at least 1
year before enrollment. They had to be in good health, with no history of any
tobacco-related disease, and could not be taking any medication for depression
or cardiovascular diseases.
Each volunteer signed an informed consent form that was approved by the
Institutional Review Board of the American Health Foundation (Valhalla, NY)
and was paid for participation in the study. Eligible subjects were interviewed in
our laboratories by a trained interviewer who used a structured questionnaire to
obtain a detailed smoking history and data on occupational exposures, diet,
family medical history, and other lifestyle factors. The smoking history included
the age at onset of smoking, the brand name and type of cigarettes (length and
whether filter-tipped, menthol, hard pack, or soft pack), and, for every brand
smoked, the quantity of cigarettes and the number of years of smoking. Detailed
brand information was needed to assign the correct FTC smoke yield because
several cigarette varieties with different FTC yields are marketed under the same
brand name. Subjects were asked to demonstrate how they hold the cigarette
while puffing to determine whether they block filter-tip vents with fingers or
lips. Questions required for calculation of the Fagerstro¨m index for nicotine
dependence were also asked(14,32).Height and weight were measured to permit
calculation of body mass index (weight in kilograms divided by the square of the
height in meters). Each participant was given a 4-day supply of his or her own
cigarette brand and instructions on how to collect cigarette butts that were to be
brought back to the laboratory. The returned butts were used to validate the
subject’s self-reported number of cigarettes smoked per day, to estimate the
average length of cigarette usually smoked, and to evaluate whether or not air
vents on the filter tips were blocked during smoking. The number of self-
reported and actual cigarettes per day, as determined by the number of cigarette
butts, correlated well (r 4 .95), indicating reasonably accurate reporting by
study participants. Filter blocking is important because some smokers of low-
yield cigarettes block the air flow through the ventilation holes on the filter tips
by lips or fingers to increase uptake of nicotine to a desired level(17,33).The
degree of blocking filter vents was determined by observation using the so-called
“bull’s-eye” method (33), whereby blocking is determined by observing the
circular pattern of the “tar” stain at the filter tip when viewed end-on. A com-
pletely stained surface indicates complete blocking, a smaller circular stain at the
center of the tip with white on the periphery (the bull’s-eye) indicates no block-
ing, and incomplete staining of the peripheral circle indicates partial blocking.
The length of cigarette smoked was used to assess smoking topography, defined
a the physical characteristics of smoke inhalation including puff volume, du-
ration, frequency, and interval between puffs. Each smoker was asked to extin-
guish the cigarette when it reached a mark that corresponded to the usual butt
length, as determined by averaging the lengths of the cigarette butts collected
from that individual. This average length also served to guide the machine
smoking of cigarettes that corresponded to the parameters of the same individual.
Assessment of Smoking Topography
Smoking topography was ascertained with the Tobacco Smoke Inhalation
Testing System(26,27),a microcomputer-assisted flow transducer that deter-
mines the flow of smoke from a lit cigarette as it is smoked by measuring the
pressure difference between two sites within an orifice flow meter(34).We used
this apparatus to evaluate 56 smokers of low-yield cigarettes (25 men and 31
women) and 77 smokers of medium-yield cigarettes (38 men and 39 women).
Each subject smoked his or her regular cigarette brand twice with the Tobacco
Smoke Inhalation Testing System, which records the foregoing topographic
parameters for each puff, their average values per cigarette, and the total volume
of smoke delivered per cigarette. Before smoking, each individual’s cigarette
was inserted in the holder with open or covered ventilation holes on the filter tip
according to the smoker’s usual habit. Smoking was halted when the cigarette
glow reached a mark that was determined from the average measured butt length
for that individual. After smoking a cigarette with the Tobacco Smoke Inhalation
Testing System, the smoker was asked to exhale into a carbon monoxide breath
analyzer (Vitalograph BreathCO; Vitalograph Inc., Lenexa, KS). Ten minutes
later, the breath analysis was repeated. When the subject indicated readiness to
smoke a second cigarette, the Tobacco Smoke Inhalation Testing System was
again used to record all parameters. Carbon monoxide in exhaled breath was
measured immediately after taking the last puff of the second cigarette and again
10 minutes later. The subject later smoked a third cigarette normally, without
using the Tobacco Smoke Inhalation Testing System. The correlation between
carbon monoxide levels obtained with the two modes of smoking was very high
(r 4 .90). This suggests that the smoking parameters determined by the Tobacco
Smoke Inhalation Testing System truly reflect human smoking and are not
artifacts attributable to the laboratory smoking environment. To minimize diur-
nal variation in smoking habits, appointments were scheduled for early afternoon
(usually between 1 and 2PM). Reproducibility of the Tobacco Smoke Inhalation
Testing System data was assessed by evaluating the coefficient of variation in the
smoking topography measurements for three smokers. By use of the Tobacco
Smoke Inhalation Testing System, subject E21/4 smoked his customary low-
yield cigarette four times on the same day, subject E26/69 smoked his customary
low-yield cigarette on five different days over a 4-month period, and subject
E21/1 smoked his medium-yield cigarette on different days over a 9-month
period. The coefficient of variation for the puff volume was not greater than 10%
for any of these individuals, and the coefficient of variation for the number of
puffs per cigarette ranged from zero for one smoker to 11.0% and 15.6% for the
two other smokers. The frequency with which puffs were drawn during smoking
showed a greater degree of variation, i.e., between 14.0% and 21.4%. However,
intraindividual variation of the total volume of smoke inhaled did not exceed
10.1%, indicating that the assessment of smoking patterns by the Tobacco
Smoke Inhalation Testing System reliably reflected the behavior of smokers of
low-yield filter cigarettes(27,28).
Machine Smoking of Cigarettes
The average smoking parameters per cigarette from two recordings with the
Tobacco Smoke Inhalation Testing System for each individual were pro-
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grammed into a one-channel, piston-type smoking machine, and then cigarettes
were smoked under conditions simulating the smoking habits of each subject for
his or her customary cigarette brand. Special attention was paid to open or
blocked filter vents during machine smoking. Before machine smoking, ciga-
rettes were inserted into the holder with the vent holes open or inserted with the
vents that were blocked fully or partially with invisible tape. Cigarettes were
smoked to the butt length that was determined for each individual from the 4-day
collection of butts.
Mainstream Smoke Assays
The mainstream smoke generated via the smoking machine programmed with
topographic smoking parameters from individual study participants was ana-
lyzed for tar, nicotine, carbon monoxide, BaP, and NNK, as described elsewhere
(35–45). Each compound of interest was assayed in triplicate in the smoke
collected from the smoking of four cigarettes under parameters obtained for each
participant studied. For these assays, a group of 72 study participants, consisting
of 30 smokers of low-yield cigarettes and 42 smokers of medium-yield ciga-
rettes, was chosen at random from the pool of 133 smokers (56 smokers of
low-yield cigarettes [ø0.8 mg of nicotine per cigarette] and 77 smokers of
medium-yield cigarettes [0.9–1.2 mg of nicotine per cigarette]). We also mea-
sured smoke yields under FTC conditions of the 11 brands of cigarettes most
frequently smoked by study subjects to obtain yields of BaP and NNK, which are
not reported by the FTC.
Statistical Evaluation
Our primary hypotheses for this study were as follows: 1) that the actual
amount of tar and nicotine taken in by smokers statistically significantly ex-
ceeded the measured levels based on FTC machine smoking of cigarettes and 2)
that the actual volume, duration, and frequency of smoke inhalation differed
statistically significantly from the values obtained by use of the protocol pre-
scribed by the FTC for machine smoking.
We tested the first hypothesis by comparing FTC mainstream smoke yields of
tar and nicotine with amounts derived from machine smoking of identical ciga-
rettes according to the topographic parameters determined for each smoker.
Comparisons were restricted to those participants for whom both sets of mea-
sures were available and are reported separately for smokers of low- and me-
dium-yield cigarettes. The statistical significance of the difference between lev-
els of smoke components measured by use of human versus FTC-prescribed
smoking topographies was evaluated with paired two-tailed Student’st te ts,
after the logarithmic transformation of the dependent variables.
We tested the second hypothesis with one-sample, two-tailed Student’st test
to evaluate the differences between the observed values and the values from the
FTC protocol for puff volume, puff duration, and puff interval. The statistical
significance of the differences was evaluated with a Student’st di tribution, and
the analyses were carried out separately for smokers of low- and medium-yield
cigarettes after logarithmic transformation of the data.
All P values were subsequently adjusted for 10 multiple comparisons through
a Bonferroni’s adjustment. In addition, secondary hypotheses were explored only
through summary statistics. Data for carbon monoxide are shown for compara-
tive purposes because carbon monoxide is the only other mainstream smoke
c mponent that is routinely reported by the FTC. However, independent statis-
tical comparisons were not performed for carbon monoxide, which is highly
correlated with levels of tar and nicotine. Because the majority of the variables
originally were not normally distributed, all data were subjected to logarithmic
transformation and, therefore, are presented as the geometric mean and its 95%
confidence interval (CI). The majority of all variables examined and all measures
included in the primary hypothesis testing were normalized by logarithmic trans-
formation. All P values are two-sided.
RESULTS
Age and smoking habits of study participants are presented
separately for smokers of low- and medium-yield cigarettes in
Table 1. The two groups were similar in current age, age at
smoking onset, duration of smoking, number of cigarettes
smoked per day, and Fagerstro¨m index but differed (by design)
in the average FTC-rated amounts of nicotine, tar, and carbon
monoxide from the cigarettes usually smoked (0.7, 8.5, and 9.7
mg in the low-yield group and 1.1, 15.4, and 14.6 mg in the
medium-yield group, respectively).
In Table 2, the smoking patterns of smokers of FTC-rated
low- and medium-yield cigarettes are compared. Furthermore,
these patterns are contrasted with the values obtained from the
FTC machine-smoking protocol itself. These variables did not
differ substantially between the two groups of smokers, except
that total volume of smoke per cigarette was 18% greater for
Table 1.Characteristics of smokers by type of cigarette as defined by Federal








(n 4 77 smokers;
0.9–1.2 mg of
nicotine/cigarette)
FTC nicotine, mg/cigarette 0.7 (0.6–0.8) 1.11 (1.09–1.13)
FTC tar, mg/cigarette 8.5 (7.7–9.5) 15.4 (15.0–15.8)
FTC carbon monoxide,
mg/cigarette
9.7 (9.0–10.4) 14.6 (14.2–14.9)
Age, y 34.1 (31.3–37.2) 34.7 (32.5–37.1)
Age at onset of smoking, y 15.9 (15.1–16.8) 15.4 (14.6–16.3)
Total years of smoking 15.7 (13.0–19.1) 17.1 (14.8–19.8)
Current No. of cigarettes
smoked/day
14.9 (13.1–16.9) 15.9 (14.3–17.8)
Fagerstro¨m index† 3.3 (2.3–4.8) 3.8 (2.7–5.3)
*Data for low- and medium-yield cigarettes are the geometric mean (95%
confidence interval). The FTC protocol specifies a 35-mL 2-second puff once
per minute.
†Fagerstro¨m index (32) is a test of nicotine dependence.
Table 2.Smoking characteristics observed in 133 smokers and values from the Federal Trade Commission (FTC) protocol for machine smoking of cigarettes*
Characteristic
Observed value
Low-yield cigarettes (n4 56 smokers;
ø0.8 mg of nicotine/cigarette)
Medium-yield cigarettes (n4 77 smokers;
0.9–1.2 of nicotine mg/cigarette)
Value from the
FTC protocol
Puff volume, mL† 48.6 (45.2–52.3) 44.1 (40.8–46.8) 35
Puff duration, sec 1.5 (1.4–1.7) 1.5 (1.4–1.6) 2
Puff interval, sec 21.3 (19.0–23.8) 18.5 (16.5–20.6) 58
Puff No. 12.7 (11.8–13.6) 12.1 (11.3–12.9) (8–10)‡
Total volume, mL/cigarette 615 (566–668) 523 (487–561) (280–350)‡
Total volume, L/day 9.5 (8.0–11.2) 8.2 (7.1–9.5) —
Blocked filter vents, % 21 30
*Data for low- and medium-yield cigarettes are the geometric mean (95% confidence interval). The FTC protocol specifies a 35-mL 2-second puff once per minute.
†Puff volume measurements were from 47 smokers of low-yield cigarettes and 71 smokers of medium-yield cigarettes.
‡Varies with length of cigarette smoked.
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smokers of low-yield cigarettes than for the total volume from
medium-yield cigarettes. However, this was partially compen-
sated by a slightly greater average number of cigarettes smoked
per day by individuals in the latter group, resulting in a similar
daily total smoke volume for both groups. Similar proportions of
low- and medium-yield smokers blocked the vents of their ciga-
rette filters.
Table 2 also shows that the values of topographic parameters
prescribed by the FTC for machine smoking differed markedly
from the values measured in smokers of both types of cigarettes.
For example, the average volume of smoke taken in with each
puff by smokers of low- and medium-yield cigarettes differed
very little (48.6 versus 44.1 mL, respectively). However, both
were statistically significantly higher than the FTC puff volume
of 35.0 mL (P<.001). More than three fourths of the smokers of
both types of cigarettes drew puffs greater than 35.0 mL. Fur-
thermore, more than two thirds of the smokers puffed more
frequently. Compared with the values specified by the FTC pro-
tocol, our subjects had shorter puff durations (1.5 versus 2 sec-
onds), puffed at much more frequent intervals (19–21 versus 58
seconds), took more puffs per cigarette (12 or 13 versus 8–10
puffs), and inhaled a considerably greater total volume of smoke
per cigarette (523–615 mL versus 280–350 mL, respectively).
None of the FTC values fell within the 95% CIs of the corre-
sponding smoking parameters that we measured in smokers of
either cigarette type.
In Table 3, we compare the “delivered doses” per cigarette of
nicotine, tar, and carbon monoxide measured in smokers of low-
and medium-yield cigarettes with the corresponding FTC values.
The FTC values for nicotine, tar, and carbon monoxide were
from the annual FTC listings published for each cigarette variety
used by our subjects. Average yields are shown per cigarette and
per day; the per-day amount for each smoker was obtained by
multiplying the per-cigarette yield by the number of cigarettes
smoked per day, as observed from a 4-day collection of butts.
Table 3 also shows that, on a per-cigarette basis, the ratio of
measured values to FTC values ranged from 2.2 to 2.5 for nico-
tine and from 1.9 to 2.6 for tar.
In Table 4, we show delivered doses of BaP and NNK de-
livered to smokers in this study. We also measured BaP and
NNK concentrations in mainstream smoke with the FTC proto-
col by machine smoking the six most popular low-yield brands
and the five most popular medium-yield brands. The delivered
dose ranged from 60% to 80% higher than the FTC dose. There
was no overlap between the 95% CIs of delivered dose and the
FTC dose for NNK in smokers of either type of cigarette or for
BaP intake in low-yield smokers. There was, however, a small
overlap of 95% CIs for BaP intake in medium-yield smokers.
The average delivered dose of BaP was slightly higher to smok-
ers of medium-yield cigarettes than to smokers of low-yield
cigarettes, but the doses of NNK were far higher.
DISCUSSION
Our data show that low- and medium-yield cigarettes deliver
to the smoker, respectively, between 2.6 and 1.9 times the
amount of tar and 2.5 and 2.2 times the amount of nicotine
obtained by smoking these cigarettes under FTC machine-
smoking conditions. Although the brands smoked by study par-
ticipants are not necessarily representative of all low- and me-
dium-yield cigarettes, they encompass a range of nicotine that
accounts for about 80% of all cigarettes smoked in the United
States. The absence of meaningful differences between the way
smokers of low- and medium-yield cigarettes smoke suggests
that the differences in delivered doses between these two groups
must be related to the differences in the cigarettes themselves,
such as tobacco blends or physical properties of materials used
in manufacturing [e.g., cigarette paper porosity and filter-tip
ventilation (7–10)].
On a per-cigarette basis, smokers of medium-yield cigarettes
received higher doses of nicotine and tar and, more important,
Table 3.Measured tar, nicotine, and carbon monoxide intake of smokers of low- and medium-yield cigarettes per cigarette and per day,
in comparison to values from Federal Trade Commission (FTC) ratings*
Measurement
Low-yield cigarettes
(ø0.8 mg of nicotine/cigarette)
Medium-yield cigarettes
(0.9–1.2 mg of nicotine/cigarette)
No. of subjects Value No. of subjects Value
Nicotine, mg/cigarette FTC rating 56 0.7 (0.6–0.8) 77 1.11 (1.09–1.13)
Measured 30 1.74 (1.54–1.98) 42 2.39 (2.20–2.60)
Measured/FTC 2.5 2.2
Nicotine, mg/day FTC rating 56 10.3 (8.9–11.9) 77 17.7 (16.0–19.7)
Measured 30 27.3 (21.7–34.3) 42 42.6 (35.6–51.1)
Measured/FTC 2.7 2.4
Tar, mg/cigarette FTC rating 56 8.5 (7.7–9.5) 77 15.4 (15.0–15.8)
Measured 18 22.3 (18.8–26.5) 19 29 (25.8–32.5)
Measured/FTC 2.6 1.9
Tar, mg/day FTC rating 56 127 (109–149) 77 245 (220–274)
Measured 18 312 (259–376) 19 571 (434–752)
Measured/FTC 2.5 2.3
Carbon monoxide, mg/cigarette FTC rating 56 9.70 (9.0–10.4) 77 14.6 (14.2–14.9)
Measured 15 17.3 (15.0–20.1) 16 22.5 (20.3–25.0)
Measured/FTC 1.8 1.5
Carbon monoxide, mg/day FTC rating 56 144 (125–166) 77 232 (208–258)
Measured 15 242 (192–304) 16 483 (369–633)
Measured/FTC 1.7 2.1
*Values for low- and medium-yield cigarettes are the geometric mean (95% confidence interval). The ratio of our measured value to the FTC rating valueis also
shown. The FTC protocol specifies a 35-mL 2-second puff once per minute.
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also BaP and NNK than did smokers of low-yield cigarettes.
When administered to rodents, NNK elicits adenocarcinoma and
BaP evokes squamous cell carcinoma of the lung(46); these are
the two most common histologic types of lung cancer in humans
(11).Per-cigarette dose is important, especially for nicotine, be-
cause it strongly affects the smoker’s behavior and, therefore,
intake of carcinogens. However, the daily dose received by
smokers may be a more relevant indicator of cancer risk. The
measured daily amounts of nicotine, tar, and carbon monoxide
were 1.7–2.7 times as great as the corresponding FTC method-
based amounts, both for smokers of low-yield cigarettes and for
smokers of medium-yield cigarettes (allP<.001) The observed
daily doses of BaP and NNK were 1.5–1.7 times as high as the
corresponding doses based on FTC method measurements.
The average dose of nicotine delivered to smokers, whether
expressed per cigarette or per day, was statistically significantly
higher than the FTC smoke yields of nicotine (for medium-yield
smokers, 2.39 versus 1.11 mg per cigarette or 42.6 versus 17.7
mg/day, respectively). This supports a finding by Benowitz et al.
(47) who showed that individuals who smoked 16 cigarettes per
day had twice as much nicotine and cotinine in plasma as indi-
viduals who received 24 1-mg doses of nicotine in nasal spray
per day. (Nicotine nasal spray differs from other recently mar-
keted nicotine medications in that nicotine is absorbed rapidly
from the nose and produces psychologic effects that resemble
effects of an equal dose of inhaled cigarette smoke.) Our obser-
vations suggest a need to re-evaluate the doses of nicotine that
are recommended in smoking cessation programs and of nico-
tine-based medications for the treatment of nicotine addiction(14).
Our data strongly support the conclusion of the Expert Com-
mittee from the National Cancer Institute(48) that FTC listings
of tar and nicotine, which have been published since 1967, do
not offer the public sound information on which to base critical
decisions with regard to health risks. This conclusion was based
in part on the recognition that human smoking conditions differ
considerably from the parameters of the FTC smoking-machine
protocol. Although nothing in the listings themselves encourages
smokers to engage in “comparison shopping” for lower risk
cigarettes, such comparisons by unwary smokers are inevitable.
The FTC recently proposed a major revision to the protocol(31)
that specifies more intense puffing conditions (56-mL puff vol-
ume, 2-second puff duration, 26-second puff interval, and block-
ing air vents on the filter tips of cigarettes), conditions that
reflect human smoking more realistically than the current pro-
tocol. The FTC proposal needs to be evaluated by use of realistic
human smoking data generated by methods such as those used in
this study. Although low-yield cigarettes delivered lower levels
of carcinogens to the smoker than did medium-yield cigarettes,
the proportional reductions expected of the former were less
than would be predicted by the FTC ratings. In other words, a
smoker who uses the FTC ratings to choose a brand of cigarettes
with lower amounts of carcinogenic agents will not achieve the
reduction anticipated. It is, therefore, somewhat misleading to
use published FTC tar and nicotine ratings as a guide for risk
assessment of the potential carcinogenicity of low-yield ciga-
rettes.
Finally, regulation of the levels of nicotine, tar, and other
armful constituents in tobacco smoke frequently figures in
broader proposals for regulation of tobacco products. Any pro-
posal that would regulate the concentrations of constituents in
mainstream cigarette smoke needs to be cognizant of their strong
ependence on the measurement protocol used.
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